They showed how piceatannol significantly inhibited VEGF-mediated signalling and cell proliferation in VEGF-treated colon cancer cells (HT-29), as well as suppressed VEGF-mediated angiogenesis in zebrafish embryos [64]. This evidence concerns the gene VEGFA and malignant colon neoplasm.